Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
International
United States
●Association of Surgical Technologists (AST): Guidelines for best practices for treatment of surgical patients experiencing malignant hyperthermia in the operating room (2005, revised 2018)
Europe
●EMHG: Guidelines on availability of dantrolene for the management of malignant hyperthermia crises (2020)
●EMHG: Recommendations on occupational exposure to volatile anaesthetics (2020)
●EMHG: Recommendations on malignant hyperthermia during pregnancy (2019)
●EMHG: Recommendations for perioperative management of MH suspected or susceptible patients (2018)
●EMHG: Guidelines for the investigation of malignant hyperthermia susceptibility (2015)
●EMHG: Guidelines for recognizing and managing a malignant hyperthermia crisis (2010)
United Kingdom
●Association of Anaesthetists: Guidelines on malignant hyperthermia, 2020 (published 2021)
Australia-New Zealand
●Malignant Hyperthermia Group of Australia and New Zealand (MHANZ): Malignant hyperthermia resource kit (revised 2018)
Japan
●[In English] Japanese Society of Anesthesiologists (JSA): Guideline for the management of malignant hyperthermia crisis, 2016 (published 2017)
●[In Japanese] JSA: Guidelines for the management of patients with malignant hyperthermia (2016)